NIPH Clinical Trials Search

JRCT ID: jRCT1051200148

Registered date:05/03/2021

Osaka Study for COVID-19 vaccine at Geriatric facilities

Basic Information

Recruitment status Complete
Health condition(s) or Problem(s) studiednone
Date of first enrollment08/03/2021
Target sample size300
Countries of recruitment
Study typeObservational


Primary Outcomeimmunogenicity
Secondary Outcomeeffectiveness, side effects after vaccination, vaccine associatd adverse events, immunogenicity based on the neutralizing antibody

Key inclusion & exclusion criteria

Age minimum>= 20age old
Age maximumNot applicable
Include criteria1. Residents and staffs at Osaka geriatric intermediate care facilities who wish to receive COVID-19 vaccine 2. Those who can follow the study schedule during the follow-up period 3. Written informed consent
Exclude criteria1. Those who have a condition under the contraindications for vaccination 2. Those who are judged to be inappropriate as study subjects by the investigator

Related Information


Public contact
Name Satoko Ohfuji
Address 1-4-3, Asahi-machi, Abeno-ku, Osaka, 545-8585, Japan Osaka Japan 545-8585
Telephone +81-6-6645-3756
Affiliation Osaka Metropolitan University Graduate School of Medicine
Scientific contact
Name Hiroyuki Nakata
Address 112, Ooujihara, Takatsuki-city, Osaka, 569-1051, Japan Osaka Japan 569-1051
Telephone +81-72-687-0103
Affiliation Keai Health Service Faciity For The Elderly